Catalyst Event
Alnylam Pharmaceuticals Inc (ALNY) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
6/4/2026, 12:00:00 AM
Announced a strategic collaboration with Inceptive Nucleics on June 4, 2026, to use AI in the discovery of RNAi therapies. The deal is valued at up to $2 billion, including a $30 million upfront payment, and the stock rose approximately 4%.
Korean Translation
2026년 6월 4일 RNAi 치료제 발견에 AI를 활용하기 위해 인셉티브 뉴클레익스와의 전략적 제휴를 발표함. 해당 계약은 3,000만 달러의 선급금을 포함하여 최대 20억 달러 규모이며, 주가는 약 4% 상승함.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day in New York City to provide updates on strategy and long-term financial plans is scheduled. Impact estimated at >=1% as analyst days usually provide incremental updates; the event is scheduled.
9/16/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's Q2 FY2027 earnings release is scheduled.
8/20/2026, 12:00:00 AM
Lumentum Holdings Inc (LITE) · Earnings Release
Lumentum's next earnings release for Q4 2026 is scheduled for August 11, 2026; high importance as a primary volatility driver scheduled.
8/11/2026, 12:00:00 AM
Conocophillips (COP) · Earnings Release
As quarterly results typically drive price movements exceeding 10% for major energy producers, the Q2 2026 earnings release on 2026-08-06 is scheduled.
8/6/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Second Quarter 2026 financial results and conference call are scheduled for 2026-08-06 scheduled.
8/6/2026, 12:00:00 AM
Kratos Defense & Security Solutions Inc (KTOS) · Earnings Release
Kratos is expected to announce its Q2 2026 earnings on 2026-08-06, with analysts forecasting an EPS of approximately $0.14. This event is estimated to have a ≥5% price impact and is scheduled.
8/6/2026, 12:00:00 AM